// App-Quantinova.ai

13993 2014 AHA : Impact of Prasugrel Pretreatment and Timing of Coronary Artery Bypass Grafting on Clinical Outcomes of Patients With Non-ST-Segment Elevation Myocardial Infarction: From the Accoast Study

Researchers

Presenter

  • Petr Widimsky

Principal Investigators

  • Leonardo Bolognese

  • Patrick Goldstein

  • Christian Hamm

  • Jean-Francois Tanguay

  • LeRoy LeNarz

  • Debra L. Miller

  • Eileen Brown

  • Jurrien M. ten Berg

  • Gilles Montalescot

Medical Centers

  • Third Medical Faculty Charles Univ and Univ. Hosp Kralovske Vinohrady, Prague, Czech Republic

  • Lille Univ Hosp, Lille, France

  • St Antonius Hospital, Nieuwegein, Netherlands

  • Jagiellonian Univ Medical Coll, Univ Hosp, Krakow, Poland

  • Ctr Hospier Univire PitieSalpetriere, Paris, France

  • Kerckhoff Heart Center, Bad Nauheim, Germany

  • Azienda Ospedaliera Arezzo, Arezzo, Italy

  • Montreal Heart Institute, Montreal, Quebec, Canada

Locations

  • Czech Republic

  • Canada

  • Italy

  • Netherlands

  • Poland

  • Germany

  • France

Companies

  • Eli Lilly and Compan

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Myocardial infarction

  • Peripheral artery disease

  • Left main disease

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • Prasugrel

  • Grace

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved